Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT04056234
Eligibility Criteria:
Inclusion Criteria:
* patients presenting with RA according to ACR87 and ACR/EULAR 2010 criteria
* patients presenting with RA anti-citrullinated peptide antibodies positive
* patients presenting with active RA, characterized by at least one synovitis
* patients presenting with an arthritis requiring arthrocentesis and synovial fluid collection for diagnostic or therapeutic purpose
* patients giving agreement to participate to the study and to sign informed consent.
Exclusion Criteria:
* patients suffering from osteoarthritis
* patients presenting with joint effusion justifying an arthrocentesis and synovial fluid collection for diagnostic of therapeutic purpose
* patients giving agreement to participate to the study and to sign informed consent
* Patients presenting with another arthropathy than anti-citrullinated peptide antibodies positive RA or osteoarthritis
* Patients not requiring arthrocentesis for medical reasons
* Patients refusing to sign informed consent
* Patients presenting with understanding problems due to language or cognitive reasons.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04056234
Study Brief:
Protocol Section:
NCT04056234